Study to assess relative bioavailability and safety of AZD5718 in healthy volunteers

Trial Identifier: D7551C00003
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: February 2021
Primary Completion Date: March 2021
Study Completion Date: March 2021
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
United Kingdom London, United Kingdom, HA1 3UJ